Baker Bros. Advisors LP Immunocore Holdings PLC Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,515,318 shares of IMCR stock, worth $50 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
1,515,318
Previous 1,515,318
-0.0%
Holding current value
$50 Million
Previous $98.5 Million
47.86%
% of portfolio
0.68%
Previous 1.25%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
152Shares Held
39.8MCall Options Held
157KPut Options Held
139K-
Wellington Management Group LLP Boston, MA6.38MShares$210 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$161 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$98.7 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$93.4 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$64.4 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.45B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...